publication venue for
- Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials.. 20:689-698. 2023
- Partner engagement for planning and development of non-pharmacological care pathways in the AIM-Back trial.. 20:463-472. 2023
- Performance of Cox regression models for composite time-to-event endpoints with component-wise censoring in randomized trials.. 20:507-516. 2023
- The design and conduct of a pragmatic cluster randomized trial of an advance care planning program for nursing home residents with dementia.. 19:-. 2022
- Clinical studies sponsored by digital health companies participating in the FDA's Precertification Pilot Program: A cross-sectional analysis.. 19:119-122. 2021
- Characteristics of available studies and dissemination of research using major clinical data sharing platforms.. 18:657-666. 2021
- Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation.. 18:732-740. 2021
- A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic.. 18:514-517. 2021
- US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018.. 18:488-499. 2021
- A case study of ascertainment bias for the primary outcome in the Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) trial.. 18:207-214. 2021
- Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial.. 18:449-456. 2021
- Randomized controlled trial of an education-based intervention to improve medication adherence: Design considerations in the medication adherence in glaucoma to improve care study.. 18:343-350. 2021
- Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials.. 17:723-728. 2020
- Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations.. 17:729-731. 2020
- Commentary on Bertagnolli et al.: Leveraging electronic health record data for clinical trials-a brave new world.. 17:243-246. 2020
- Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews.. 17:231-234. 2019
- Caregiver-guided pain coping skills training for patients with advanced cancer: Background, design, and challenges for the CaringPals study.. 16:263-272. 2019
- The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation.. 15:243-246. 2018
- The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements.. 15:219-229. 2018
- The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.. 11:362-375. 2014
- Adherence reporting in randomized controlled trials.. 11:195-204. 2013
- Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power.. 9:232-46. 2012
- A model for the design and implementation of a participant recruitment registry for clinical studies of older adults.. 9:204-14. 2012
- Using audit information to adjust parameter estimates for data errors in clinical trials.. 9:721-9. 2012
- Lessons learned from an osteoporosis clinical trial in frail long-term care residents.. 9:247-56. 2011
- Insights from the conduct of a device trial in older persons: low magnitude mechanical stimulation for musculoskeletal health.. 7:354-67. 2010
- The Hip Impact Protection Project: design and methods.. 5:347-55. 2008
- Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.. 4:218-34. 2007
- Experimental designs for multicomponent interventions among persons with multifactorial geriatric syndromes.. 2:13-21. 2005